Cargando…
Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy?
Contrast-induced nephropathy (CIN) remains a leading cause of iatrogenic acute kidney injury, as the usage of contrast media for imaging and intravascular intervention keeps expanding. Diabetes is an important predisposing factor for CIN, particularly in patients with renal functional impairment. Re...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856131/ https://www.ncbi.nlm.nih.gov/pubmed/24350240 http://dx.doi.org/10.1155/2013/123589 |
_version_ | 1782295026412290048 |
---|---|
author | Heyman, Samuel N. Rosenberger, Christian Rosen, Seymour Khamaisi, Mogher |
author_facet | Heyman, Samuel N. Rosenberger, Christian Rosen, Seymour Khamaisi, Mogher |
author_sort | Heyman, Samuel N. |
collection | PubMed |
description | Contrast-induced nephropathy (CIN) remains a leading cause of iatrogenic acute kidney injury, as the usage of contrast media for imaging and intravascular intervention keeps expanding. Diabetes is an important predisposing factor for CIN, particularly in patients with renal functional impairment. Renal hypoxia, combined with the generation of reactive oxygen species, plays a central role in the pathogenesis of CIN, and the diabetic kidney is particularly susceptible to intensified hypoxic and oxidative stress following the administration of contrast media. The pathophysiology of this vulnerability is complex and involves various mechanisms, including a priori enhanced tubular transport activity, oxygen consumption, and the generation of reactive oxygen species. The regulation of vascular tone and peritubular blood flow may also be altered, particularly due to defective nitrovasodilation, enhanced endothelin production, and a particular hyperresponsiveness to adenosine-related vasoconstriction. In addition, micro- and macrovascular diseases and chronic tubulointerstitial changes further compromise regional oxygen delivery, and renal antioxidant capacity might be hampered. A better understanding of these mechanisms and their control in the diabetic patient may initiate novel strategies in the prevention of contrast nephropathy in these susceptible patients. |
format | Online Article Text |
id | pubmed-3856131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38561312013-12-16 Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? Heyman, Samuel N. Rosenberger, Christian Rosen, Seymour Khamaisi, Mogher Biomed Res Int Review Article Contrast-induced nephropathy (CIN) remains a leading cause of iatrogenic acute kidney injury, as the usage of contrast media for imaging and intravascular intervention keeps expanding. Diabetes is an important predisposing factor for CIN, particularly in patients with renal functional impairment. Renal hypoxia, combined with the generation of reactive oxygen species, plays a central role in the pathogenesis of CIN, and the diabetic kidney is particularly susceptible to intensified hypoxic and oxidative stress following the administration of contrast media. The pathophysiology of this vulnerability is complex and involves various mechanisms, including a priori enhanced tubular transport activity, oxygen consumption, and the generation of reactive oxygen species. The regulation of vascular tone and peritubular blood flow may also be altered, particularly due to defective nitrovasodilation, enhanced endothelin production, and a particular hyperresponsiveness to adenosine-related vasoconstriction. In addition, micro- and macrovascular diseases and chronic tubulointerstitial changes further compromise regional oxygen delivery, and renal antioxidant capacity might be hampered. A better understanding of these mechanisms and their control in the diabetic patient may initiate novel strategies in the prevention of contrast nephropathy in these susceptible patients. Hindawi Publishing Corporation 2013 2013-11-21 /pmc/articles/PMC3856131/ /pubmed/24350240 http://dx.doi.org/10.1155/2013/123589 Text en Copyright © 2013 Samuel N. Heyman et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Heyman, Samuel N. Rosenberger, Christian Rosen, Seymour Khamaisi, Mogher Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? |
title | Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? |
title_full | Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? |
title_fullStr | Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? |
title_full_unstemmed | Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? |
title_short | Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? |
title_sort | why is diabetes mellitus a risk factor for contrast-induced nephropathy? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856131/ https://www.ncbi.nlm.nih.gov/pubmed/24350240 http://dx.doi.org/10.1155/2013/123589 |
work_keys_str_mv | AT heymansamueln whyisdiabetesmellitusariskfactorforcontrastinducednephropathy AT rosenbergerchristian whyisdiabetesmellitusariskfactorforcontrastinducednephropathy AT rosenseymour whyisdiabetesmellitusariskfactorforcontrastinducednephropathy AT khamaisimogher whyisdiabetesmellitusariskfactorforcontrastinducednephropathy |